Tabriz University of Medical Sciences Depiction of Health 2008-9058 17 1 2026 03 24 Trends, Collaborations, and Thematic Structure of Global ScientificPublications in the Field of Wilms Tumor: A Scientometric Analysis 28 43 10.34172/doh.2026.04 EN Ashkan Isari https://orcid.org/0000-0002-4873-8384 Hadi Salehpour https://orcid.org/0009-0003-2590-4647 Hanieh Salehi-Pourmehr https://orcid.org/0000-0001-9030-2106 Behzad Lotfi https://orcid.org/0000-0001-8835-8151 Journal Article 10.34172/doh.2026.04 2025 07 26 2025 10 21 Background. Wilms tumor (nephroblastoma) is one of the most common malignant kidney cancers in childhood, accounting for approximately 6% of all pediatric cancers. Given the increasing volume of research in this field, a scientometric analysis has become essential to evaluate the scientific structure, research trends, and identify existing gaps in the literature. Methods. This study employs a descriptive-analytical approach with a scientometric methodology. Data were extracted from the Scopus database using keywords related to Wilms tumor up to November 2024. Analytical tools included Bibliometrix software (R package) and VOSviewer. Key metrics examined were annual publication trends, authorship and country collaboration networks, citation metrics, top journals and institutions, and keyword co-occurrence analysis. Results. A total of 14,049 scientific documents were identified from 1934 to 2025. The United States, China, and Japan contributed the highest scientific output. Pediatric Blood and Cancer and Journal of Pediatric Surgery were among the most cited journals in this field. Frequent keyword analysis revealed increasing trends in topics related to WT1 gene, biomarkers, targeted therapies, and genetic syndromes (e.g., Denys-Drash). Collaboration networks highlighted the central role of developed countries in knowledge production. Conclusion. This study confirms the growing research interest in Wilms tumor. However, an uneven geographical distribution of scientific output and research gaps in patient-specific genetics, novel therapies, and multi-omics studies remain evident. These findings can assist health policymakers, research institutions, and researchers in planning future studies in pediatric cancers, particularly Wilms tumor.